Dalbavancin Injection, Powder, For Solution
Product Images NDC 0480-3325

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dalbavancin (NDC 0480-3325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Dalbavancin Structural Formula (Dalbavancin For Injection A219465 1)

FDA Label Image

Carton (Dalbavancin For Injection A219465 2)

Carton (Dalbavancin For Injection A219465 2)
500 mg per vial of Dalbavancin for intravenous infusion, for single use only. The sterile single-dose vial is suitable for unused portion preservation. This medication is intended for infusion purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.